Khalid El Bairi: Cancer Research and Care Beyond Borders for Global Oncologist Dario Trapani
Khalid El Bairi shared a post on LinkedIn:
”I’m excited to share this new op-ed published in the ASCO Post, where I interviewed Dr. Dario Trapani, a truly inspiring medical oncologist and figure in global oncology. His ongoing contributions have significantly impacted the field. I am proud to have him as both a mentor and a friend in my career, someone who has profoundly influenced my vision and progress. Find more about this interview here.”
Source: Khalid El Bairi/LinkedIn
Khalid El Bairi, founder of The Cancer Biomarkers Working Group, specializes in clinical and translational research in medical oncology. With many peer-reviewed articles, he delves into predictive and prognostic cancer biomarkers, especially for digestive and gynecological cancers like ovarian and colorectal malignancies. El Bairi holds board positions in international scientific societies such as IGCS, ESMO, ASCO, ESGO, and AACR. Serving as editor and reviewer for over 40 journals, he also educates medical and Ph.D. students on evidence-based medicine, research methodologies, and publishing ethics.
Dario Trapani, MD, is a medical oncologist at the European Institute of Oncology, IRCCS, Milan and Assistant Professor at the Department of Oncology and Haemato-Oncology of the University of Milan, in Italy. He has been the first ESMO-seconded consultant to the World Health Organization (WHO) within the Cancer Control team.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023